(firstQuint)Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis.

 The purpose of this study is to evaluate the safety, efficacy, and tolerability of a 0.

5% BID concentration of RVT-501 in pediatric patients 2-17 years of age with mild to moderate atopic dermatitis.

 The pharmacokinetics of RVT-501 will also be evaluated in patients 2-11 years of age.

.

 Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis@highlight

This is a multi-center, randomized, vehicle controlled, double-blind Phase 2 study in pediatric patients age 2-17 years old with mild to moderate atopic dermatitis.

